MICHAEL W BONNEY Insider Trading $KLDO Kaleido Biosciences, Inc.
Get free email notifications about insider trading for MICHAEL W BONNEY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL W BONNEY. MICHAEL W BONNEY is Director in BRISTOL MYERS SQUIBB CO ($BMY) and in CELGENE CORP /DE/ ($CELG) and Director in CELGENE CORP /DE/ ($CELG) and Director in NPS PHARMACEUTICALS INC ($NPSP) and Chief Executive Officer in CUBIST PHARMACEUTICALS INC ($CBST) and President & CEO in CUBIST PHARMACEUTICALS INC ($CBST) and President and CEO in CUBIST PHARMACEUTICALS INC ($CBST) and Director in Sarepta Therapeutics, Inc. ($SRPT) and Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Global Blood Therapeutics, Inc. ($GBT) and Director in Tekla World Healthcare Fund ($THW) and Director in Magenta Therapeutics, Inc. ($MGTA) and Director in Kaleido Biosciences, Inc. ($KLDO) and Executive Chair in Kaleido Biosciences, Inc. ($KLDO).
MICHAEL W BONNEY in Kaleido Biosciences, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MICHAEL W BONNEY: Director, Executive Chair
Holdings: 1,005,968 shares
Latest Transaction: Jul 01 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL W BONNEY in Kaleido Biosciences, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNY, BMY, CELG, CBST, GBT, KLDO, MGTA, NPSP, SRPT, SYRS, THW
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 01 2020 | KLDO | Kaleido Bioscience ... | BONNEY MICHAEL W | Director | Option Exercise | A | 7.42 | 15,000 | 111,300 | 15,000 | |
| Mar 04 2019 | KLDO | Kaleido Bioscience ... | BONNEY MICHAEL W | Executive Chair | Option Exercise | C | 0.00 | 450,000 | 0 | 0 | |
| Mar 04 2019 | KLDO | Kaleido Bioscience ... | BONNEY MICHAEL W | Executive Chair | Option Exercise | C | 0.00 | 835,347 | 0 | 0 | |
| Mar 04 2019 | KLDO | Kaleido Bioscience ... | BONNEY MICHAEL W | Executive Chair | Buy | C | 0.00 | 225,000 | 0 | 225,000 | 0 to 225 K |
| Mar 04 2019 | KLDO | Kaleido Bioscience ... | BONNEY MICHAEL W | Executive Chair | Buy | C | 0.00 | 417,673 | 0 | 1,426,196 | 1 M to 1.4 M (+41.41 %) |
| Mar 04 2019 | KLDO | Kaleido Bioscience ... | BONNEY MICHAEL W | Executive Chair | Buy | P | 14.65 | 2,555 | 37,431 | 1,008,523 | 1 M to 1 M (+0.25 %) |
| Mar 04 2019 | KLDO | Kaleido Bioscience ... | BONNEY MICHAEL W | Executive Chair | Buy | P | 13.95 | 68,965 | 962,062 | 1,005,968 | 937 K to 1 M (+7.36 %) |
Page: 1